Erik Anders Kronström
Chief Operating Officer bei INFANT BACTERIAL THERAPEUTICS AB
Vermögen: 89 953 $ am 30.04.2024
Aktive Positionen von Erik Anders Kronström
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| INFANT BACTERIAL THERAPEUTICS AB | Chief Operating Officer | 01.01.2018 | - |
| Chief Tech/Sci/R&D Officer | 20.10.2014 | 01.01.2018 |
Karriereverlauf von Erik Anders Kronström
Ehemalige bekannte Positionen von Erik Anders Kronström
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Biosergen AS
 Biosergen AS BiotechnologyHealth Technology Biosergen AS develops drugs based on biosynthetic engineering of natural products, combined with chemical synthesis. It develops antibiotics for the use in antifungal therapy. The firm uses engineered biosynthesis technology that allows alterations in microbial genes, which lead to predictable changes in the final structure of the natural product. The company was founded in 2004 and is headquartered in Tiller, Norway. | Chief Executive Officer | - | - |
Ausbildung von Erik Anders Kronström
| Warwick Business School | Masters Business Admin |
| Royal Institute of Technology | Graduate Degree |
Statistik
International
| Schweden | 3 |
| Vereinigtes Königreich | 2 |
| Norwegen | 2 |
Operativ
| Chief Executive Officer | 1 |
| Graduate Degree | 1 |
| Masters Business Admin | 1 |
Sektoral
| Consumer Services | 3 |
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| INFANT BACTERIAL THERAPEUTICS AB | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Biosergen AS
Biosergen AS BiotechnologyHealth Technology Biosergen AS develops drugs based on biosynthetic engineering of natural products, combined with chemical synthesis. It develops antibiotics for the use in antifungal therapy. The firm uses engineered biosynthesis technology that allows alterations in microbial genes, which lead to predictable changes in the final structure of the natural product. The company was founded in 2004 and is headquartered in Tiller, Norway. | Health Technology |
- Börse
- Insiders
- Erik Anders Kronström
- Erfahrung
